|
Revenue
|
0.61M | 1.36M |
|
Cost of Revenue
|
2.54M | 1.81M |
|
Gross Profit
|
-0.12M | 0.37M |
|
Depreciation & Amortization - Total
|
0.21M | 0.07M |
|
Research & Development
|
2.01M | 1.27M |
|
Selling, General & Administrative
|
2.37M | 1.24M |
|
Restructuring Costs
|
0.14M | 0.43M |
|
Other Operating Expenses
|
3.87M | 3.49M |
|
Operating Expenses
|
8.59M | 6.49M |
|
Operating Income
|
-8.71M | -6.12M |
|
EBIT
|
-8.71M | -6.12M |
|
Interest & Investment Income
|
0.06M | 0.09M |
|
EBT
|
-8.66M | -6.03M |
|
Profit After Tax
|
-9.01M | -6.54M |
|
Income from Continuing Operations
|
-8.66M | -6.03M |
|
Consolidated Net Income
|
-8.66M | -6.03M |
|
Income towards Parent Company
|
-8.66M | -6.03M |
|
Net Income towards Common Stockholders
|
-8.66M | -6.03M |
|
EPS (Basic)
|
-0.00M | -0.00M |
|
EPS (Weighted Average and Diluted)
|
-0.00M | -0.00M |
|
Shares Outstanding (Weighted Average)
|
14.56M | 14.60M |
|
EBITDA
|
-8.50M | -6.05M |